Searching for an individualized EEG marker for predicting treatment outcome in PTSD

Searching for an individualized EEG marker for predicting treatment outcome in PTSD - EEG marker for treatment outcome in PTSD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41229

Enrollment

Registered

2012-05-08

Start date

2012-08-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PTSD en stress disorder

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients: - Patients with a diagnosis of chronic PTSD with symptom duration > 3 months - CAPS score of * 45 - Male and female, aged 18 years and above - Written informed consent - Eligible for exposure therapy;Controls: - Meeting the stressor A criterion of DSM-IV PTSD - Male and female, aged 18 years and above - Written informed consent

Exclusion criteria

Exclusion criteria: Patienten: - Suicidal risk - Presence of any of the following DSM IV diagnoses: psychotic disorder incl. schizophrenia, a bipolar disorder, depression with psychotic features, or excessive substance related disorder. - Primary diagnosis of severe depressive disorder

Design outcomes

Primary

Measure	Time frame
We will first examine differences in the deviant-stimuli induced alpha suppression between PTSD and controls. We will then see how these differences in PTSD individuals relate to their treatment outcome.	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results